Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Bloomberg Analysts Now See a 75% Chance A Spot Bitcoin ETF Will Launch In 2023
  2. XRP's Bullish Breakout: A Beacon of Hope for Bitcoin?
  3. Bitcoin ($BTC) Price Mirroring Previous Bottom Formations, Says Popular Crypto Analyst
  4. Cryptos Rise, XRP Now Ranked 4th Overall
  5. Cathie Wood: SEC Staff Understand Bitcoin and Its Merits